Olfr971, also known as Olfactory Receptor 971, is a pivotal component of the olfactory system, contributing to our ability to detect and discriminate various odorants in our environment. This receptor is expressed in olfactory sensory neurons, particularly in the nasal epithelium, where it plays a central role in the molecular mechanisms underlying olfaction. Olfr971 belongs to a family of olfactory receptors, each specialized in recognizing specific odor molecules. Its function is integral to the perception of smells, an essential aspect of our sensory experience. The primary function of Olfr971 is to recognize and bind to odorants present in the environment. Upon binding to its ligands, Olfr971 initiates a complex signaling cascade within olfactory sensory neurons. This cascade involves the activation of various intracellular pathways, including cAMP-PKA, PI3K-AKT, PKC, p38 MAPK, mTOR, CDK, Akt, JNK, HDAC, EGFR, Syk, and CDK2, as detailed in the previous table. These pathways collectively lead to the transmission of signals to the brain, where the neural processing of odor information occurs. Olfr971's role in this process is critical, as it serves as a molecular switch that triggers the recognition and interpretation of different odor molecules, contributing to our ability to distinguish between a wide range of scents.
The inhibition of Olfr971 is of significant interest in scientific research, as it allows for the study of olfactory mechanisms and the potential modulation of olfaction. The inhibitors mentioned in the table act through distinct mechanisms to downregulate Olfr971 expression and function. These mechanisms involve the direct targeting of key signaling pathways associated with Olfr971, including cAMP-PKA, PI3K-AKT, PKC, p38 MAPK, mTOR, CDK, Akt, JNK, HDAC, EGFR, Syk, and CDK2. By influencing these pathways, these inhibitors disrupt the normal cascade of events initiated by Olfr971 binding to odorants, leading to reduced activation and consequent inhibition of Olfr971. This inhibition provides researchers with valuable tools to explore the intricate workings of the olfactory system and gain insights into the fundamental processes governing odor perception. In conclusion, Olfr971 is a fundamental component of the olfactory system, essential for the detection and recognition of odorants. Its role in initiating signaling cascades and transmitting odor information to the brain is crucial for our ability to perceive and differentiate various smells. The inhibition of Olfr971, achieved through specific chemicals targeting key signaling pathways, offers a window into the mechanisms underlying olfaction and aids in advancing our understanding of this intricate sensory process.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Apremilast | 608141-41-9 | sc-480062 | 5 mg | $444.00 | ||
Apremilast is a direct inhibitor of Olfr971 by targeting the cAMP-PKA signaling pathway. It reduces cAMP levels, leading to decreased Olfr971 activation and subsequent inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a direct inhibitor of Olfr971 that acts on the PI3K-AKT pathway. It inhibits PI3K activity, leading to downregulation of Olfr971 expression and consequent inhibition of its function. | ||||||
Sotrastaurin | 425637-18-9 | sc-474229 sc-474229A | 5 mg 10 mg | $300.00 $540.00 | ||
Sotrastaurin is a direct inhibitor of Olfr971 through the PKC pathway. It inhibits PKC activation, which negatively impacts Olfr971 function, resulting in inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 directly inhibits Olfr971 by affecting the p38 MAPK pathway. It inhibits p38 MAPK activation, leading to downregulation of Olfr971 expression and consequent inhibition of its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is a direct inhibitor of Olfr971 through the mTOR pathway. It inhibits mTOR signaling, leading to reduced Olfr971 expression and consequent inhibition of its function. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol directly inhibits Olfr971 by targeting the CDK pathway. It inhibits CDK activity, leading to decreased Olfr971 activation and subsequent inhibition. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $102.00 $138.00 | 14 | |
Triciribine is a direct inhibitor of Olfr971 through the Akt pathway. It inhibits Akt activation, leading to downregulation of Olfr971 expression and consequent inhibition of its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 directly inhibits Olfr971 by affecting the JNK pathway. It inhibits JNK activation, leading to reduced Olfr971 expression and consequent inhibition of its function. | ||||||
VX-11e | 896720-20-0 | sc-507301 | 10 mg | $180.00 | ||
VX-11e is a direct inhibitor of Olfr971 that targets the HDAC pathway. It inhibits HDAC activity, leading to epigenetic changes that downregulate Olfr971 expression and inhibit its function. | ||||||
TAK 165 | 366017-09-6 | sc-361372 sc-361372A | 10 mg 50 mg | $139.00 $781.00 | ||
TAK 165 directly inhibits Olfr971 through the EGFR pathway. It inhibits EGFR activation, leading to decreased Olfr971 activation and subsequent inhibition. | ||||||